Psilocybin Science and Research

This review examines the cardiovascular effects of psilocybin, LSD, and mescaline, highlighting safety in healthy users while outlining risks for at-risk populations.

This review of a recent publication in the Journal of Psychopharmacology explores whether psilocybin could help treat postpartum depression by improving mood and bonding, and examines early safety data for breastfeeding.

A first-of-its-kind clinical trial finds that low-dose LSD is safe for adults with ADHD but no more effective than placebo, underscoring the power of expectancy.

We describe the most groundbreaking research in this area, including the most recent studies. This will enable you to get a better sense of not only how psilocybin can improve your mental health but also how to maximize these benefits.

The study aimed to investigate the impact of discontinuing serotonergic antidepressants (SSRIs/SNRIs) prior to psilocybin therapy compared to continuing treatment with escitalopram for individuals with major depressive disorder (MDD).

This article delves into the current research, ongoing studies, and practical considerations surrounding this question, aiming to provide a comprehensive resource for mental health professionals and the general public interested in psychedelic treatments.

The study aimed to investigate how psilocybin affects brain activity during meditation and whether it enhances meditative states.

This article reviews the latest meta-analysis on esketamine for depression, highlighting modest clinical effects, safety concerns, and its potential to reduce healthcare costs.

This study reviews emerging evidence on the interplay between sleep and psilocybin therapy, highlighting how sleep quality may influence treatment outcomes for depression.

This meta-analysis explores psilocybin's effectiveness and safety in treating major depressive disorder (MDD), with a particular focus on dose-response relationships and optimal timing of therapeutic effects.

This study explored how psilocybin combined with meditation and spiritual practices influences long-term psychological functioning and prosocial behaviors.

The end-to-end Odyssey experience is modeled after best practices used in modern clinical trials and psychedelic research studies. This article describes the many ways in which our evidence-based approach is built on a foundation of science, from the ground up.

Safety is our highest priority. Psilocybin experiences can be extremely powerful, and we believe they should be handled with intention, care, and respect. Accordingly, safety has been thoroughly considered through every step of the Odyssey process

This article delves into how challenging psychedelic experiences, when properly supported, can serve as catalysts for profound personal transformation.

This clinical trial explores how psilocybin therapy alters personality traits like neuroticism and impulsiveness, and how these changes may support addiction recovery.